RDHL.TA - RedHill Biopharma Ltd.

Tel Aviv - Tel Aviv Delayed Price. Currency in ILS
Income Statement
Balance Sheet
Cash Flow

Income Statement

Currency in USD. All numbers in thousands
Total Revenue8,3604,0071013
Cost of Revenue2,8372,126--
Gross Profit5,5231,8811013
Operating Expenses
Research Development24,86232,96925,24117,771
Selling General and Administrative19,99220,0395,4034,134
Non Recurring----
Total Operating Expenses47,69155,13430,64421,905
Operating Income or Loss-39,331-51,127-30,543-21,902
Income from Continuing Operations
Total Other Income/Expenses Net5115,5831,173812
Earnings Before Interest and Taxes-39,331-51,127-30,543-21,902
Interest Expense-42-77-7-12
Income Before Tax-38,820-45,544-29,370-21,090
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-38,820-45,544-29,370-21,090
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-38,820-45,544-29,370-21,090
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-38,820-45,544-29,370-21,090